- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lunar adds volume imaging to Artoscan
Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging. Lunar, of Madison, WI, will release
Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging.
Lunar, of Madison, WI, will release a new software packageat the RSNA meeting called Version 3.3 B. The package includes3-D imaging sequences and multiformat reconstruction and givesArtoscan the ability to conduct volume imaging, according to BillConn, MRI marketing manager.
Lunar is also introducing a remote diagnostics capability forthe scanner, dubbed Artoscan Remote Assistance System (ARAS).ARAS allows Lunar engineers to maintain, diagnose and providesoftware upgrades for Artoscan via modem.
Artoscan was cleared for marketing by the Food and Drug Administrationlate last year (SCAN 11/3/93). Lunar has sold 60 units worldwideand eight in the U.S., Conn said. The company expects have a U.S.installed base of 10 to 12 units by the end of the year.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
